Related references
Note: Only part of the references are listed.Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
Hyung-Jun Yoon et al.
BMC PSYCHIATRY (2013)
Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit
Juliana Barr et al.
CRITICAL CARE MEDICINE (2013)
Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial
Benchalak Maneeton et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Antipsychotic use and diagnosis of delirium in the intensive care unit
Joshua T. Swan et al.
CRITICAL CARE (2012)
Postoperative delirium. Part 1: pathophysiology and risk factors
Luzius A. Steiner
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2011)
Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults A Systematic Review and Meta-analysis
Alicia Ruelaz Maher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium
Sandeep Grover et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2011)
Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study
John W. Devlin et al.
CRITICAL CARE MEDICINE (2010)
Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial
Timothy D. Girard et al.
CRITICAL CARE MEDICINE (2010)
Risperidone versus olanzapine for the treatment of delirium
Sung-Wan Kim et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
A randomized controlled trial of quetiapine versus placebo in the treatment of delirium
Tayyeb A. Tahir et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2010)
A randomized controlled, pilot study of aripiprazole in the treatment of delirium
S. W. Jung et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Risperidone vs. haloperidol in treatment of delirium superimposed on dementia
G. Djokic et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Occurrence and outcome of delirium in medical in-patients: a systematic literature review
Najma Siddiqi et al.
AGE AND AGEING (2006)
Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
LS Schneider et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study
KU Lee et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials
LS Schneider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Olanzapine vs haloperidol: treating delirium in a critical care setting
YK Skrobik et al.
INTENSIVE CARE MEDICINE (2004)
A double-blind trial of risperidone and haloperidol for the treatment of delirium
CS Han et al.
PSYCHOSOMATICS (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?
L McAuley et al.
LANCET (2000)
Share Paper
